Showing results (611-620 of 683) with videos related to

Sort By:
Pageof 69
Journal of the American College of Radiology : JACR|November 2, 2024
ACR Appropriateness Criteria® Penetrating Torso Trauma, James T Lee, Ahmed Sobieh, et al.
Plos One|November 21, 2024
Clinical staff reported knowledge on the existence of clinical governance protocols or tools utilised in selected South African hospitalsNomfuneko Sithole, Wezile W Chitha, Onke R Mnyaka, et al.
JCO Oncology Practice|February 13, 2020
Gender Differences in Faculty Rank and Leadership Positions Among Hematologists and Oncologists in the United StatesIrbaz Bin Riaz, Rabbia Siddiqi, Umar Zahid, et al.
The Egyptian Heart Journal : (EHJ) : Official Bulletin of the Egyptian Society of Cardiology|July 10, 2024
Comparison of long-term clinical outcomes of bioabsorbable polymer versus durable polymer drug-eluting stents: a systematic review and meta-analysisAbdur Rehman, Ifra Eeman Ahmed, Ahmed Nouman, et al.
BMC Endocrine Disorders|November 29, 2022
Safety and efficacy of Empagliflozin in Pakistani Muslim patients with type 2 diabetes (SAFE-PAK); a randomized clinical trialAzizul Hasan Aamir, Umar Yousaf Raja, Faisal Masood Qureshi, et al.
Ecological Applications : a Publication of the Ecological Society of America|February 12, 2026
Artificial surface water broadens the spatiotemporal footprint of herbivores and alters species responsesRobert A McCleery, Sam M Ferreria, Philip Mhlava, et al.
BMJ Open|November 25, 2022
Early risk assessment in paediatric and adult household contacts of confirmed tuberculosis cases by novel diagnostic tests (ERASE-TB): protocol for a prospective, non-interventional, longitudinal, multicountry cohort studyEdson Tawanda Marambire, Denise Banze, Alfred Mfinanga, et al.
BMC Infectious Diseases|May 28, 2025
DRTB-HDT: a randomized controlled trial of two adjunctive host-directed therapies in rifampin-resistant tuberculosisNestani Tukvadze, Sehlomola Mashatole, Anne Jacobs, et al.
Leukemia & Lymphoma|February 10, 2022
Gender disparities in the National Institutes of Health funding for hematologic malignancies and cellular therapiesRaheel Sufian Siddiqui, Sibgha Gull Chaudhary, Moazzam Shahzad, et al.
Communications Medicine|February 14, 2026
Host response biomarkers of tuberculosis recurrence and treatment failureBernadette Bauer, Mohamed I M Ahmed, Olga Baranov, et al.
Pageof 69